Court Blocks Trump’s EU Tariffs, Wall Street Sees Modest Gains✎ Contributed by Ty Griffin A U.S. federal court has blocked President Donald Trump’s move to impose...
stocks
Newton Golf Company (NASDAQ: NWTG) Releases Financial Report, Business Highlights for Q1 2025✎ Contributed by Ty Griffin Newton Golf reports three-figure revenue growth in first quarter of 2025. Newton...
Musk Rebukes Trump’s Economic Plan, EV Stocks Diverge✎ Contributed by Ty Griffin Elon Musk openly criticized President Donald Trump’s proposed “Big Beautiful Bill,” targeting...
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval✎ Contributed by Ty Griffin Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with...
Newton Golf Company (NASDAQ: NWTG) Unveils Fast Motion Shaft for Next-Level Play, Game-Changing Innovation✎ Contributed by Ty Griffin Newton Golf’s new Fast Motion shaft exemplifies how a company can use...
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year✎ Contributed by Ty Griffin Disseminated on behalf of SolarBank Corporation Total assets rose to $194 million...
Trump’s Tariff Delay Boosts Market Confidence as Indices Climb✎ Contributed by Ty Griffin President Donald Trump has postponed a proposed 50% tariff on European Union...
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 6.9 MW Community Solar Project in Nova ScotiaDisseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will develop the...
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute AcquisitionKadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network of psychiatric...
Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand GrowsIntelligent Bio Solutions remains on track for a 2025 U.S. launch of its non-invasive Intelligent Fingerprinting Drug...
